Zhang Qianwen, Ding Yu, Feng Biyun, Tang Yijun, Chen Yao, Wang Yirou, Chang Guoying, Liu Shijian, Wang Jian, Li Qian, Fu Lijun, Wang Xiumin
Department of Endocrinology and Metabolism, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Department of Clinical Epidemiology and Biostatistics, Shanghai Children's Medical Center, School of Medicine, Shanghai Jiao Tong University, Shanghai, China.
Front Genet. 2022 Feb 8;13:808919. doi: 10.3389/fgene.2022.808919. eCollection 2022.
Alström syndrome (ALMS) is a rare inherited metabolic disease and ciliopathy. Large cohorts of ALMS are lacking around the world. Detailed genetic and phenotypic data were obtained from all affected individuals. Olfactory function was evaluated by the Chinese Smell Identification Test and facial pattern was analyzed with Face2gene. Fifty ALMS patients were included in this study, aged from 0.3 to 21.7 years old. Sixty-one variants in 50 patients from 47 different families were confirmed, including 59 truncating and two exon deletions. Twenty-four of those variants were novel. We also summarized all previously reported cases of Chinese ALMS patients (69 patients) and identified specific and common variants within the Chinese population. Besides, the Chinese Smell Identification Test scores in patients was lower than that in controls (11.97 Vs. 10.44, < .05), indicating olfactory identification impairments in ALMS patients. The facial pattern in ALMS patients was also distinctive from that of the controls ( < .05). In conclusion, this is the largest cohort of Chinese ALMS patients. We have successfully identified both specific and common variants in our cohort. We found a new phenotype of olfactory impairments in ALMS patients through a case-control study.
阿尔斯特伦综合征(ALMS)是一种罕见的遗传性代谢疾病和纤毛病。世界各地缺乏大量的阿尔斯特伦综合征患者队列。我们从所有受影响个体中获取了详细的基因和表型数据。通过中国嗅觉识别测试评估嗅觉功能,并用Face2gene分析面部特征。本研究纳入了50例阿尔斯特伦综合征患者,年龄从0.3岁到21.7岁。确认了来自47个不同家庭的50例患者中的61个变异,包括59个截短变异和2个外显子缺失。其中24个变异是新发现的。我们还总结了之前报道的所有中国阿尔斯特伦综合征患者病例(69例),并确定了中国人群中的特异性和常见变异。此外,患者的中国嗅觉识别测试得分低于对照组(11.97对10.44,P<0.05),表明阿尔斯特伦综合征患者存在嗅觉识别障碍。阿尔斯特伦综合征患者的面部特征也与对照组不同(P<0.05)。总之,这是最大的中国阿尔斯特伦综合征患者队列。我们在我们的队列中成功识别了特异性和常见变异。通过病例对照研究,我们发现了阿尔斯特伦综合征患者嗅觉障碍的新表型。